Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.

Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.

There are currently no effective therapies for fibrodysplasia ossificans progressiva (FOP), a debilitating and progressive heterotopic ossification disease caused by activating mutations of ACVR1 encoding the BMP type I receptor kinase ALK2. Recently, a subset of these same mutations of ACVR1 have b...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Mohedas, A, Wang, Y, Sanvitale, C, Canning, P, Choi, S, Xing, X, Bullock, A, Cuny, G, Yu, P
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2014

Eitemau Tebyg

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.
gan: Chaikuad, A, et al.
Cyhoeddwyd: (2012)

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva
gan: Chaikuad, A, et al.
Cyhoeddwyd: (2012)

Investigation of kinase activation in fibrodysplasia ossificans progressiva
gan: Sanvitale, CE
Cyhoeddwyd: (2014)

FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
gan: Mehul M Gosai, et al.
Cyhoeddwyd: (2013-03-01)

Fibrodysplasia ossificans progressiva
gan: Chané Smit, et al.
Cyhoeddwyd: (2023-11-01)

Development of macrocycle kinase inhibitors for ALK2 using Fibrodysplasia ossificans progressiva‐derived endothelial cells
gan: Sánchez‐Duffhues, G, et al.
Cyhoeddwyd: (2019)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
gan: Williams, E, et al.
Cyhoeddwyd: (2021)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
gan: Eleanor Williams, et al.
Cyhoeddwyd: (2021-04-01)

Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva‐Derived Endothelial Cells
gan: Gonzalo Sánchez‐Duffhues, et al.
Cyhoeddwyd: (2019-11-01)

Fibrodysplasia Ossificans Progressiva: Case Report
gan: Enver Şimşek, et al.
Cyhoeddwyd: (2015-12-01)

The Fibrodysplasia Ossificans Progressiva and Bone Scintigraphy
gan: Sofia CHKIKAR, et al.
Cyhoeddwyd: (2024-04-01)

Immunologic Aspects in Fibrodysplasia Ossificans Progressiva
gan: Anastasia Diolintzi, et al.
Cyhoeddwyd: (2024-03-01)

Recent Topics in Fibrodysplasia Ossificans Progressiva
gan: Takenobu Katagiri, et al.
Cyhoeddwyd: (2018-09-01)

Fibrodysplasia ossificans progressiva: case report
gan: ANAMARLI NUCCI, et al.
Cyhoeddwyd: (2000-06-01)

Challenges and opportunities for drug repositioning in Fibrodysplasia ossificans progressiva
gan: Ventura, F, et al.
Cyhoeddwyd: (2021)

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
gan: Francesc Ventura, et al.
Cyhoeddwyd: (2021-02-01)

Fibrodysplasia ossificans progressiva: Lumps, bumps and biologics
gan: Atukorala, I, et al.
Cyhoeddwyd: (2007)

Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva.
gan: Virdi, A, et al.
Cyhoeddwyd: (1999)

Fibrodysplasia ossificans progressiva: a case report
gan: Merih Önal, et al.
Cyhoeddwyd: (2014-10-01)

Fibrodysplasia Ossificans Progressiva - An Uncommon Cause of Trismus
gan: Ravi Sankaran, et al.
Cyhoeddwyd: (2022-07-01)

Fibrodysplasia ossificans progressiva: Two case reports
gan: Yodit Abraham Yaynishet, et al.
Cyhoeddwyd: (2024-08-01)

Pay Attention to the Osteochondromas in Fibrodysplasia Ossificans Progressiva
gan: Longqing Li, et al.
Cyhoeddwyd: (2024-03-01)

Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva
gan: Fatima Khan, et al.
Cyhoeddwyd: (2021-02-01)

Fibrodysplasia Ossificans Progressiva in an Adult Indian Male
gan: Rachit Harjai, et al.
Cyhoeddwyd: (2014-08-01)

Fibrodysplasia ossificans progressiva-like in a cat
gan: L.Z. Crivelenti, et al.
Cyhoeddwyd: (2012-04-01)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
gan: Pignolo Robert J, et al.
Cyhoeddwyd: (2011-12-01)

Fibrodysplasia Ossificans Progressiva: A Case Report
gan: Anoop C Dhamangaonkar, et al.
Cyhoeddwyd: (2013-12-01)

Fibrodysplasia ossificans progressiva mimicking as fibroma with hypospadias
gan: Varun Kaul, et al.
Cyhoeddwyd: (2018-01-01)

Fibrodysplasia ossificans progressiva: A case report
gan: Sreedhar Vasala
Cyhoeddwyd: (2014-05-01)

Fibrodysplasia ossificans progressiva: A case report
gan: Ahmed Al Mustaque, et al.
Cyhoeddwyd: (2014-01-01)

Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives
gan: Smilde BJ, et al.
Cyhoeddwyd: (2022-04-01)

Development of BMP type I receptor kinase inhibitors for the treatment of fibrodysplasia ossificans progressiva and the study of the BMP signaling pathway
gan: Mohedas, Agustin Humberto
Cyhoeddwyd: (2014)

Fibrodysplasia Ossificans Progressiva: Literature Review and Case Report
gan: Natalya N. Korableva, et al.
Cyhoeddwyd: (2023-01-01)

Early Recognition of Fibrodysplasia Ossificans Progressiva-Important For the Clinician
gan: Ankur Singh, et al.
Cyhoeddwyd: (2016-06-01)

Early Recognition of Fibrodysplasia Ossificans Progressiva-Important For the Clinician
gan: Ankur Singh, et al.
Cyhoeddwyd: (2016-06-01)

Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification
gan: Conan Juan, et al.
Cyhoeddwyd: (2024-03-01)

Fibrodysplasia Ossificans Progressiva: A rare case series
gan: Lokesh kumar Sekaran, et al.
Cyhoeddwyd: (2023-12-01)

Clinical Features, Diagnosis and Management of Fibrodysplasia Ossificans Progressiva
gan: ZHAO Junduo, et al.
Cyhoeddwyd: (2023-10-01)

Role of Imaging in A Case of Fibrodysplasia Ossificans Progressiva
gan: Rachit Harjai, et al.
Cyhoeddwyd: (2015-07-01)

A CASE OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA WITH PRIMARY AMENORRHEA
gan: Ayesha zafar, et al.
Cyhoeddwyd: (2011-06-01)